Dr Simona Soverini discusses early molecular response, next-generation sequencing, and the impact of tyrosine kinase inhibitor-resistant mutations in various leukaemias.
Join our mailing list
To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now